Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 21;22(1):1020.
doi: 10.1186/s12889-022-13407-2.

Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online survey

Yasue Fukuda  1 , Moemi Saito  2
Affiliations

Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online survey

Yasue Fukuda et al. BMC Public Health. .

Abstract

Background: This study examined warning messages as a strategy for preventing automobile crashes by drivers on medications. We investigated the degree of awareness regarding the effects of medication on automobile driving and changes in medication-taking and driving behavior. We also assessed associations between socio-environmental factors and the driving and medication-taking behavior adopted by individuals after being warned about driving-related risks.

Methods: Responses to an online questionnaire from 1200 people with a driving license who were taking prescription medications at the time of inquiry (March 2019) were collected and analyzed. The items surveyed were sex, age, educational history, health literacy, current medications, and medication-taking and driving behavior after being warned.

Results: Of the total respondents, 30% were taking medicine that prohibited driving. Of those taking prohibited medications, 25.7% did not receive a warning about driving from healthcare professionals. Most respondents taking prohibited medications received euphemistic warnings, such as "practice caution" (30%), "refrain from calling attention" (29.4%), and "avoid driving" (19.8%); 16% of the direct warnings were about not driving. Medication's effects on driving were recognized by 80% of the total respondents. The degree of awareness was significantly higher among respondents taking medications that prohibit driving than among those taking medications that did not prohibit driving or those taking unknown medications. Awareness of medicine's influence on driving was associated with health literacy. No association was found between age, gender, health literacy, history of side effects, and driving and medication-taking behavior. Approximately 22% of respondents adjusted their medication use at their discretion and 39% maintained treatment compliance but continued driving. Among respondents taking medications that prohibit driving, whether driving was required for work was a significant factor in their driving and medication-taking behavior after being warned.

Conclusions: Healthcare professionals do not always fully inform patients about the driving-related risks of medications. To encourage patients who are taking medications that have a significant impact on their driving to either stop driving or consult a healthcare professional, healthcare professionals must first understand the patient's social environment, such as whether driving is required for work, and then create an environment conducive to advice-seeking.

Keywords: Adherence; Driving behavior; Health literacy; Medication warnings; Social environment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Warning message and driving behavior, adherence process
Fig. 2
Fig. 2
Medications taken by all participants (frequency classified by efficacy)
Fig. 3
Fig. 3
Therapeutic classes of medications taken by respondents that prohibit driving
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Movig KL, Mathijssen MP, Nagel PH, van Egmond T, de Gier JJ, Leufkens HG, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev. 2004;36:631–636. doi: 10.1016/S0001-4575(03)00084-8. - DOI - PubMed
    1. Jones AW, Kugelberg FC, Holmgren A, Ahlner J. Five-year update on the occurrence of alcohol and other medicines in blood samples from drivers killed in road-traffic crashes in Sweden. Forensic Sci Int. 2009;186:56–62. doi: 10.1016/j.forsciint.2009.01.014. - DOI - PubMed
    1. Jitkritsadakul O, Bhidayasiri R. Physicians’ role in the determination of fitness to drive in patients with Parkinson’s disease: systematic review of the assessment tools and a call for national guidelines. J Clin Mov Disord. 2016;3:14. doi: 10.1186/s40734-016-0043-x. - DOI - PMC - PubMed
    1. American Medical Association. Physician’s guide to assessing and counseling older drivers. 2nd ed. Washington: American Medical Association/National Highway Traffic Safety Administration/US Department of Transportation; 2010.
    1. Kelly E, Darke S, Ross J. A review of medicine use and driving: epidemiology, impairment, risk factors and risk perceptions. Med Alcohol Rev. 2004;23:319–344. doi: 10.1080/09595230412331289482. - DOI

Publication types

Substances

LinkOut - more resources